Programs

SAMiRNA is a modular, no-formulation micellar conjugate RNAi that enables delivery to organs beyond the liver. Around 80 nm in size and neutral in charge, SAMiRNA has excellent stability, meaning it can be delivered through versatile routes of administration

Immunology

Intravenous (IV) and subcutaneous (SC) administration delivers efficiently to immune cells, fibrotic tissues, and some solid tumors. This enables organ-agnostic tropism, meaning a single therapy could address various diseases across different organs and cell types.